Nuzenio

Tradingview Revolution Medicines

Tradingview Revolution Medicines entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 14 latest news signals 1 publisher sources 100/100 entity strength

Latest news

BlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - TradingViewTradingView · Fri, 07 Aug 2026 20:09:00 GMTRVMD Posts Wider-Than-Anticipated Loss in Q2, Lifts '26 Expense View - TradingViewTradingView · Thu, 06 Aug 2026 18:00:00 GMTRevolution Medicines, Inc. Stock 12‑Month Price Target Raised to $216.4, Implies 10% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:26 GMTRevolution Medicines Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 04:03:00 GMTRVMD: Paradigm-shifting clinical results and robust financials drive accelerated launches and pipeline progress - TradingViewTradingView · Wed, 05 Aug 2026 23:25:58 GMTRVMD: Q2 2026 marked major clinical, regulatory, and financial advances, positioning for key launches - TradingViewTradingView · Wed, 05 Aug 2026 22:33:32 GMTRevolution Medicines, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:01:46 GMTRevolution Medicines, Inc. Q2 2026: Net loss $(644.4M), EPS $(3.06) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMT

Timeline

Fri, 07 Aug 2026 20:09:00 GMTBlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - TradingView
Thu, 06 Aug 2026 18:00:00 GMTRVMD Posts Wider-Than-Anticipated Loss in Q2, Lifts '26 Expense View - TradingView
Thu, 06 Aug 2026 17:20:26 GMTRevolution Medicines, Inc. Stock 12‑Month Price Target Raised to $216.4, Implies 10% Upside - TradingView
Thu, 06 Aug 2026 04:03:00 GMTRevolution Medicines Q2 Earnings Call Highlights - TradingView
Wed, 05 Aug 2026 23:25:58 GMTRVMD: Paradigm-shifting clinical results and robust financials drive accelerated launches and pipeline progress - TradingView
Wed, 05 Aug 2026 22:33:32 GMTRVMD: Q2 2026 marked major clinical, regulatory, and financial advances, positioning for key launches - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Revolution Medicines.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.